Tsivgoulis, Georgios
Palaiodimou, Lina
Katsanos, Aristeidis H.
Voumvourakis, Konstantinos
Hadjigeorgiou, Georgios M.
Heliopoulos, Ioannis
Karapanayiotides, Theodore
Papathanasopoulos, Panagiotis
Kilidireas, Constantinos
Grigoriadis, Nikolaos
Article History
First Online: 26 February 2019
Compliance with Ethical Standards
:
: Georgios Tsivgoulis has received research support (not related to this project) from Teva Pharmaceutical Hellas, Genesis Pharma, and Novartis Hellas. Konstantinos Voumvourakis has received research support (not related to this project) from Teva Pharmaceutical Hellas, Merck Hellas, Genesis Pharma, and Novartis Hellas. Panagiotis Papathanasopoulos has received research support (not related to this project) from Biogen Idec, Novartis, TEVA, Merck Serono, and Genesis Pharma. Nikolaos Grigoriadis has received research support (not related to this project) from Biogen Idec, Novartis, TEVA, Merck Serono, and Genesis Pharma. Lina Palaiodimou, Aristeidis H. Katsanos, Georgios M. Hadjigeorgiou, Ioannis Heliopoulos, Theodore Karapanayiotides, and Constantinos Kilidireas report no sources of funding. The funding sources mentioned above had no role in the decision to publish, or the preparation of the present letter.
: Georgios Tsivgoulis, Lina Palaiodimou, Aristeidis H. Katsanos, Konstantinos Voumvourakis, Georgios M. Hadjigeorgiou, Ioannis Heliopoulos, Theodore Karapanayiotides, Panagiotis Papathanasopoulos, Constantinos Kilidireas, and Nikolaos Grigoriadis have no conflicts of interest that are directly relevant to the content of this letter.